Dr. Jesse P. Frumkin, PhD, MLA, MS
Dr. Jesse P. Frumkin, PhD, MLA, MS
Frumkin et al., "Patent eligibility after Alice: Evidence from USPTO patent examination" Journal of Economics & Management Strategy (2024)
Toole et al., "Diagnosing COVID-19: A perspective from U.S. patenting activity" (2023)
Toole et al., "Inventing AI Tracing the diffusion of artificial intelligence with U.S. patents" (2020)
deGrazia, Charles, Jesse Frumkin, and Nicholas Pairolero. "Embracing Invention Similarity for the Measurement of Vertically Overlapping Claims" Economics of Innovation and New Technology, 29(2), 113–146 (2018)
Marco, Alan C., et al. "USPTO Patent Prosecution and Examiner Performance Appraisal." (2017)
Frumkin, Jesse and Myers, Amanda F., Cancer Moonshot Patent Data (August, 2016)
Frumkin, Jesse. "Gentamicin, a read‐through agent for the treatment of rectal cancer." Colorectal Disease 19.9 (2017): 864-864.
Frumkin, Jesse P., et al. "The interplay between chromosome stability and cell cycle control explored through gene–gene interaction and computational simulation." Nucleic acids research 44.17 (2016): 8073-8085.
Patra, Biranchi, et al. "A genome wide dosage suppressor network reveals genomic robustness." Nucleic acids research 45.1 (2016): 255-270.
Paladugu, S. R., et al. "In silico evolution of functional modules in biochemical networks." IEE Proc.-Syst. Biol 153.4 (2006): 223.
Social Network Analysis using PatentsView and NetworkX
(The opinions expressed here are my own and do not reflect the views of my employer.)